Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)
Morocco · Delayed Price · Currency is MAD 1,589.00
0.00 (0.00%)
At close: Nov 14, 2025
CBSE:PRO Income Statement
Financials in millions MAD. Fiscal year is January - December.
Millions MAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 928.99 | 898.71 | 805.52 | 704.64 | 630.49 | 573.2 | Upgrade | |
Revenue Growth (YoY) | 11.80% | 11.57% | 14.32% | 11.76% | 10.00% | 9.71% | Upgrade |
Cost of Revenue | 517.18 | 508.82 | 446.27 | 332.17 | 299.96 | 272.81 | Upgrade |
Gross Profit | 411.81 | 389.89 | 359.24 | 372.47 | 330.53 | 300.38 | Upgrade |
Selling, General & Admin | 275.04 | 256.81 | 235.94 | 209.75 | 197.83 | 174.68 | Upgrade |
Other Operating Expenses | 33.35 | 26.88 | 22.64 | 28.6 | 27.77 | 24.22 | Upgrade |
Operating Expenses | 308.4 | 283.68 | 258.58 | 238.35 | 225.61 | 198.9 | Upgrade |
Operating Income | 103.41 | 106.21 | 100.66 | 134.12 | 104.92 | 101.48 | Upgrade |
Interest Expense | -11.39 | -10.15 | -4.64 | -1.42 | -0.31 | -0.09 | Upgrade |
Interest & Investment Income | 0.05 | - | 0.03 | 0.86 | 0.5 | 0.55 | Upgrade |
Currency Exchange Gain (Loss) | 5.04 | 1.93 | 2.94 | -9.92 | 1.35 | -0.3 | Upgrade |
Other Non Operating Income (Expenses) | 16.54 | 5.67 | 0.21 | -1.5 | 0.17 | -1.07 | Upgrade |
EBT Excluding Unusual Items | 113.65 | 103.66 | 99.21 | 122.14 | 106.63 | 100.57 | Upgrade |
Gain (Loss) on Sale of Assets | 0.48 | 0.13 | 0.19 | 1 | 0.03 | -0.01 | Upgrade |
Asset Writedown | -10.41 | -10.41 | - | -9.13 | - | - | Upgrade |
Other Unusual Items | -4.94 | -4.34 | -11.6 | 0.25 | -3.97 | -10.12 | Upgrade |
Pretax Income | 98.79 | 89.04 | 87.79 | 114.25 | 102.69 | 90.45 | Upgrade |
Income Tax Expense | 41.59 | 33.88 | 30.9 | 38.97 | 33.72 | 30.19 | Upgrade |
Net Income | 57.2 | 55.16 | 56.9 | 75.28 | 68.97 | 60.26 | Upgrade |
Net Income to Common | 57.2 | 55.16 | 56.9 | 75.28 | 68.97 | 60.26 | Upgrade |
Net Income Growth | 1.58% | -3.06% | -24.42% | 9.15% | 14.45% | 15.63% | Upgrade |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade |
EPS (Basic) | 57.20 | 55.16 | 56.90 | 75.28 | 68.97 | 60.26 | Upgrade |
EPS (Diluted) | 57.20 | 55.16 | 56.90 | 75.28 | 68.97 | 60.26 | Upgrade |
EPS Growth | - | -3.06% | -24.42% | 9.15% | 14.45% | 15.63% | Upgrade |
Free Cash Flow | - | 153.31 | 147.18 | 70.32 | 215.53 | - | Upgrade |
Free Cash Flow Per Share | - | 153.31 | 147.18 | 70.32 | 215.53 | - | Upgrade |
Dividend Per Share | - | - | - | 40.000 | 40.000 | - | Upgrade |
Gross Margin | 44.33% | 43.38% | 44.60% | 52.86% | 52.42% | 52.41% | Upgrade |
Operating Margin | 11.13% | 11.82% | 12.50% | 19.03% | 16.64% | 17.70% | Upgrade |
Profit Margin | 6.16% | 6.14% | 7.06% | 10.68% | 10.94% | 10.51% | Upgrade |
Free Cash Flow Margin | - | 17.06% | 18.27% | 9.98% | 34.19% | - | Upgrade |
EBITDA | 123.07 | 123.32 | 112.68 | 143.25 | - | - | Upgrade |
EBITDA Margin | 13.25% | 13.72% | 13.99% | 20.33% | - | - | Upgrade |
D&A For EBITDA | 19.66 | 17.11 | 12.02 | 9.13 | - | - | Upgrade |
EBIT | 103.41 | 106.21 | 100.66 | 134.12 | 104.92 | 101.48 | Upgrade |
EBIT Margin | 11.13% | 11.82% | 12.50% | 19.03% | 16.64% | 17.70% | Upgrade |
Effective Tax Rate | 42.10% | 38.05% | 35.19% | 34.11% | 32.84% | 33.38% | Upgrade |
Revenue as Reported | 1,057 | 971.72 | 844.21 | 746.77 | 631.59 | 637.96 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.